bsm-33195M [Primary Antibody]
Survivin Monoclonal Antibody
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Mouse

Target Protein: Survivin

Clonality: Monoclonal

Isotype: IgG

Entrez Gene: 332

Swiss Prot: O15392

Source: Recombinant human Survivin

Purification: Purified by Protein A.

Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Background:

May play a role in neoplasia. May counteract a default induction of apoptosis in G2/M phase. Interacts with tubulin. Inhibitor of caspase-3 and caspase-7. Component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Belongs to the IAP family.?

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-5000)
ELISA(1:500-1000)
IHC-P(1:200-400)
IHC-F(1:100-500)
IF(ICC)(1:50-200)
IF()

Predicted Molecular Weight: 16kDa


Cross Reactive Species: Human
Rat

For research use only. Not intended for diagnostic or therapeutic use.

VALIDATION IMAGES

Jurkat lysates probed with Survivin Polyclonal Antibody, Unconjugated (bs-33195M) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.


Lane 1: Human MOLT-4 cell lysates; Lane 2: Human U937 cell lysates probed with Survivin Monoclonal Antibody, Unconjugated (bsm-33195M) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.


Lane 1: Human MDA-MB-231 cell lysates; Lane 2: Human Jurkat cell lysates; Lane 3: Human Raji cell lysates; Lane 4: Human Hela cell lysates; Lane 5: Human MOLT-4 cell lysates; Lane 6: Human U-2OS cell lysates probed with Survivin Monoclonal Antibody, Unconjugated (bsm-33195M) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.